Showing results (461-470 of 487) with videos related to

Sort By:
Pageof 49
BJU International|June 10, 2021
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysisMizuki Kobayashi, Shintaro Narita, Yoshiyuki Matsui, et al.
Urologic Oncology|October 5, 2023
Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairmentKeita Minami, Takahiro Osawa, Takahiro Kojima, et al.
Clinical and Experimental Nephrology|February 7, 2013
Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010Hitoshi Sugiyama, Hitoshi Yokoyama, Hiroshi Sato, et al.
Cancer Science|January 4, 2026
Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in JapanShuhei Yamada, Miho Sato, Takahiro Osawa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 24, 2021
Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort studyMasayuki Yamanouchi, Kengo Furuichi, Miho Shimizu, et al.
BMJ Open Diabetes Research & Care|August 13, 2021
Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney diseaseMasayuki Yamanouchi, Kengo Furuichi, Junichi Hoshino, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 28, 2026
Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional StudySayaka Shimizu, Takahiro Osawa, Miho Sato, et al.
International Journal of Clinical Oncology|December 17, 2024
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, et al.
Annals of Surgical Oncology|February 14, 2024
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical ProstatectomyMasaki Shiota, Dai Takamatsu, Yoshiyuki Matsui, et al.
International Journal of Clinical Oncology|July 8, 2024
Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvementTokiyoshi Tanegashima, Masaki Shiota, Takahiro Kimura, et al.
Pageof 49